Inceptive
Palo Alto, US · 4 known investors
Inceptive builds foundation models of biological systems for drug discovery, specializing in sequence-based medicines like mRNA and peptides. The company combines deep learning trained on heterogeneous life data with in-house wet lab validation to design novel drug candidates that outperform existing options.
AI & Machine LearningBiotechMedical Devices
Founders & leadership
<
<UNKNOWN>
Investors · 4
In the news
- BridgeBio Secures $1 Billion Investment to Strengthen Capital Structure | Intellectiaintellectia.ai · 2026
- Alnylam expands AI partnership with Komodo Health By Investing.comza.investing.com · 2026
- Alnylam Pharmaceuticals, Inc. (ALNY) Partners with Inceptive Nucleics to Accelerate Growth as A High-Growth Large-Cap Stock - Insider Monkeyinsidermonkey.com · 2026
- City raises $99.5M to 'expand where RNAi medicines can go and what they can achieve' | FirstWord Pharmafirstwordpharma.com · 2026
- Q3 2023 Quarterly Insights — Dynamk Capitaldynamk.vc · 2023